Q & A with Anusha Preethi Ganesan, MD, PhD, Awardee of St. Baldrick’s Foundation Research Grant
|
Moores Member Dr. Anusha Preethi Ganesan has been awarded $200,000 to fund her research that addresses the lack of novel, effective treatments for Medulloblastoma, the most common malignant pediatric brain tumor, fatal in 40% of patients.
|
Living Hope Podcast: Journey with Pancreatic Cancer
|
Moores Director, Diane M. Simeone, MD, was a recent guest on the Living Hope Podcast, where she discussed her research on pancreatic cancer and her mission to improve patient survival rates.
|
|
|
Cancer Drug May Improve Cognitive Function in Autism and Other Neurologic Disorders
|
Moores Member Alysson Muotri, PhD has discovered that an experimental cancer drug may enhance cognitive function in individuals with Rett syndrome, a rare condition associated with autism, which could pave the way for new therapies for other neurological disorders.
|
Moores Member Featured on The Stem Cell Podcast
|
Catriona Jamieson, MD, PhD was a guest on The Stem Cell Podcast, where she discussed the opportunities and challenges of working with stem cells in a microgravity environment and what this means for the future of stem cell-based therapies.
|
UC San Diego, School of Medicine Recognized Among 2024 Best Medical Schools
|
The UC San Diego, School of Medicine received a Tier 1 rating from the U.S. News & World Report “2024 Best Medical Schools: Research,” an accomplishment achieved by only 16% of medical schools.
|
Moores Member Elected President of the American Society of Colon and Rectal Surgeons (ASCRS)
|
Moores Member Sonia Ramamoorthy, MD will serve as the fourth woman and first Asian woman to lead the 125-year-old ASCRS. Kudos to Dr. Ramamoorthy!
|
|
|
August 7, 2024 | 12:00 p.m. to 1:00 p.m.
Moores Comer Commons and Zoom
|
August 9, 2024 | 12:00 p.m. to 1:00 p.m.
Moores Comer Commons and Zoom
|
August 21, 2024 | 12:00 p.m. to 1:00 p.m.
Moores Comer Commons and Zoom
|
August 27, 2024 | 12:00 p.m. to 1:00 p.m.
Moores Comer Commons and Zoom
|
September 26, 2024 | 9:00 a.m. to 3:30 p.m.
Moores Goldberg Auditorium and Comer Commons
|
|
|
If you are a Moores Member who has a lab in the Moores building, Moores Research Education and Training (Cancer Research, Training, and Education Coordination—CRTEC) asks if you would be willing to host 20-minute lab tours once or twice throughout the year for small groups of high school and/or undergraduate students. CRTEC hopes to expand the number of labs that these motivated “next generation of cancer-researchers” are able to tour. This small investment of your time has a large influence on these students, and the tours are rewarding for both the students and the members of your lab.
Please reach out to Amy Spilkin, PhD at aspilkin@health.ucsd.edu if you would be willing to assist.
|
|
|
FEATURED FUNDING OPPORTUNITIES |
Department of Defense (DOD), Congressionally Directed Medical Research Programs (CDMRP) |
The DOD CDMRP Kidney Cancer Research Program (KCRP) has released the following funding opportunities:
Postdoctoral and Clinical Fellowship Award
LOI Deadline: August 15, 2024
Application Deadline: September 5, 2024
Concept Award
LOI Deadline: August 15, 2024
Application Deadline: September 5, 2024
Academy of Kidney Cancer Investigators Leadership Award (New for FY24)
LOI Deadline: August 29, 2024
Application Deadline: September 19, 2024
Academy of Kidney Cancer Investigator Early Career Scholar Award
LOI Deadline: September 24, 2024
Application Deadline: October 15, 2024
Clinical Trial Award
LOI Deadline: September 24, 2024
Application Deadline: October 15, 2024
Idea Development Award
LOI Deadline: September 24, 2024
Application Deadline: October 15, 2024
Translational Research Partnership Award
LOI Deadline: September 24, 2024
Application Deadline: October 15, 2024
|
|
|
| Baseline biomarkers of efficacy and on-treatment immune-profile changes associated with bempegaldesleukin plus nivolumab
|
Gregory A. Daniels, MD, PhD (Solid Tumor Therapeutics)
|
|
|
|
Effect of rabbit ATG PK on outcomes after TCR-αβ/CD19-depleted pediatric haploidentical HCT for hematologic malignancy
|
Eric Anderson, MD (Non-Program Member)
|
|
|
| Association of personalized and tumor-informed ctdna with patient survival outcomes in pancreatic adenocarcinoma
|
Gregory P. Botta, MD, PhD (Cancer Biology and Signaling)
|
|
|
CLINICAL TRIALS OFFICE (CTO) |
TGN-S11: A Phase 1 Trial of TGNS11 in Patients With Human Papillomavirus (HPV)Associated Relapsed, Resistant or Metastatic Cancer
|
PI: Assuntina Sacco, MD
NCT: NCT05826275
|
BO44426: A Phase Ib/II, Open-Label, Multicenter Study Evaluating the Safety, Activity, and Pharmacokinetics of GDC6036 in Combination With Other Anti-Cancer Therapies in Patients With Previously Untreated Advanced Or Metastatic Non-Small Cell Lung Cancer With a KRAS G12C Mutation
|
PI: Lyudmila Bazhenova, MD
NCT: NCT05789082
|
|
|
COMMUNITY OUTREACH AND ENGAGEMENT |
Empathic Inquiry Training
|
COE held an Empathic Inquiry Training with Moores colleagues and federally-qualified health partners. Participants gained valuable understanding of screening for social needs. COE thanks the Oregon Care Association for its support in making this training possible.
|
Cervical Cancer Quality Improvement Learning Collaborative
|
COE hosted its second session of the Cervical Cancer Quality Improvement Learning Collaborative. Over 30 participants joined to learn strategies for promoting inclusive cervical cancer screening within the LGBTQIA+ community.
|
Frederika Manor Retirement Home Information Session
|
COE Liaisons, Dahlia and Krzel, presented to over a dozen seniors at Frederika Manor Retirement Home about cancer prevention and the resources available at Moores.
|
|
|
|
